AS | Ankit Sarawagi · Founder, CFOmatrix · June 17, 2026 · 14 min read · Updated June 2026 |
Telemedicine platforms look like marketplaces on the surface: connect patients with doctors, charge a fee per consultation, grow the volume. The reality is far more complex. Your supply costs are relatively fixed because doctors must be available whether or not patients book. Your demand is episodic because most patients only consult when sick, not on a predictable schedule. And your monetization depends on whether you can turn a one-time sick-day visit into a relationship built on follow-ups, prescriptions, and diagnostics. This guide covers the 14 metrics that tell you whether your healthtech unit economics are actually working, with benchmarks calibrated for the Indian telemedicine market.
Key Takeaways
- Doctor utilization below 60% means your supply costs exceed what consultation revenue can cover
- Consult-to-repeat rate above 30% is the clearest signal that patients trust your platform enough to return
- Prescription fulfillment revenue can double your effective revenue per consultation and is the key monetization lever in telemedicine
- Patient Acquisition Cost between Rs. 200 and Rs. 800 is the viable range for Indian telemedicine, depending on specialization
- LTV:CAC of 3:1 or higher is the minimum for a sustainable healthtech business model
- NPS above 50 is a strong signal in healthcare, where trust and reliability determine whether patients return
Table of Contents
60%+ Doctor utilization rate below this means your supply costs are not being covered by consultation revenue. | 30%+ Consult-to-repeat rate that signals patients trust the platform enough to return rather than using it once. | 3x Minimum LTV:CAC for healthtech to be sustainable. Patient acquisition is expensive and must be recovered over multiple consultations. |
Why Healthtech Unit Economics Are Unique
Most digital businesses convert fixed costs into variable revenue through volume. Healthtech platforms face a different structure: the cost of having qualified doctors available is largely fixed, while patient demand is episodic and unpredictable. You cannot simply turn the supply tap up or down with a week’s notice because onboarding, credentialing, and building a reliable doctor network takes time. This creates a utilization problem that sits at the heart of telemedicine economics.
The second structural challenge is patient behavior. Healthcare is not a daily habit like a productivity tool or a weekly routine like a fitness app. Most patients consult only when symptomatic, which means your retention curve falls off sharply after a first consultation. Building repeat behavior requires not just a good experience but deliberate product decisions: follow-up reminders, chronic condition management programs, prescription refill nudges, and diagnostic tie-ins. Without these, you are running an expensive patient acquisition machine with no retention flywheel.
The third challenge is monetization depth. A single consultation fee may be Rs. 400 to Rs. 800 for a general physician. That number is hard to build a profitable business on when your Patient Acquisition Cost is Rs. 500 or more. The economics only work if you can stack revenue: consultation plus prescription fulfillment plus diagnostic orders plus follow-up consultations. Each of these layers improves LTV and changes whether the business is viable or not.
Revenue Metrics
Revenue metrics in healthtech measure both the depth of monetization per patient interaction and the productivity of the platform’s supply side. Tracking these four metrics tells you whether pricing, doctor mix, and monetization architecture are working together.
Revenue per Consultation
Revenue per Consultation is the average fee your platform earns on each completed consultation. It reflects your pricing architecture, doctor mix (general vs specialist), and whether you are capturing the full value of each interaction or leaving revenue on the table through heavy discounting.
This metric must be tracked separately by doctor category. Blending general and specialist consultations into one number hides important pricing signals.
ARPU per Patient
ARPU per Patient tracks the total monthly revenue generated per active patient on your platform. Unlike Revenue per Consultation, ARPU captures the full monetization picture including prescription fulfillment, diagnostic orders, and follow-up fees. It measures how deeply you are monetizing each patient relationship, not just each transaction.
A patient who consults once and buys medicines twice in a month generates far more ARPU than a patient who only consulted. This metric tracks whether your cross-sell and upsell architecture is working.
Revenue per Doctor
Revenue per Doctor measures the average monthly revenue each active doctor on your platform generates. It is a supply-side productivity metric that tells you whether your doctor network is sized correctly for your current demand volume, and whether your doctor onboarding and scheduling investment is translating into revenue.
Rising Revenue per Doctor over time indicates improving demand efficiency: the same doctor headcount is generating more revenue because patient volumes have grown or consultation fees have increased. Flat or declining Revenue per Doctor signals that you are adding doctors faster than demand can absorb, inflating your supply costs.
Prescription Fulfillment Revenue Rate
Prescription Fulfillment Revenue Rate measures the percentage of consultations that result in a medicine order placed through your platform. It is the most important monetization lever in telemedicine because prescription revenue can equal or exceed the consultation fee itself, dramatically improving the economics of each patient interaction.
A platform that converts 30% of consultations into pharmacy orders at an average basket of Rs. 600 generates Rs. 180 of additional revenue per consultation on top of the consultation fee. At 10 lakh consultations per year, that is Rs. 18 crore of pharmacy revenue that transforms the entire P&L.
Efficiency Metrics
Efficiency metrics in telemedicine measure how well you are using your supply. A doctor sitting idle on the platform is a cost with no corresponding revenue. These three metrics track whether your supply and demand are in balance, and whether your commission structure is capturing an appropriate share of the value being created.
Doctor Utilization Rate
Doctor Utilization Rate measures the percentage of available doctor hours that are actually used for completed consultations. It is the single most important efficiency metric in telemedicine because a low utilization rate means you are paying for supply that is not generating revenue, creating a direct drag on unit economics.
If your doctors are available for 8 hours a day but only completing consultations for 4 hours, your utilization is 50% and you are running your supply at half efficiency. Improving utilization from 50% to 70% with the same doctor headcount effectively reduces your cost per consultation by almost 30%.
Consultation Slot Fill Rate
Slot Fill Rate measures the percentage of appointment slots that were actually booked by patients out of the total slots made available by doctors. It is a demand-side signal: a low Slot Fill Rate indicates that either demand is insufficient for your current supply volume, or that your booking experience has friction that prevents patients from converting to bookings.
The Slot Fill Rate is a leading indicator of future utilization. If your slots are filling well, utilization will follow. If slots are consistently unfilled, you need to either reduce supply, improve marketing to drive demand, or fix the booking funnel before expanding doctor headcount.
Platform Commission Rate
Platform Commission Rate measures the percentage of total consultation value that the platform retains after paying out the doctor. It defines the monetization structure of the marketplace and determines how much of each consultation flows to the platform’s gross profit rather than to supply costs.
A platform earning Rs. 500 per consultation while the doctor receives Rs. 375 has a 25% commission rate. This commission rate, combined with volume, determines whether the business can cover its operating costs and invest in growth.
Patient Retention
Retention is where telemedicine unit economics succeed or fail. Healthcare is an episodic category by nature, which means you have to work harder for repeat behavior than a SaaS or e-commerce business. Each of the three metrics below measures a different dimension of whether patients are coming back, and how deeply care continuity is being built into the patient relationship.
Patient Retention Rate
Patient Retention Rate measures the percentage of patients from a given cohort who consult again on the platform within 90 days. It captures the most fundamental question in telemedicine retention: did the patient choose to come back, or did they use the platform once and move on? Repeat consultation behavior is the foundation of LTV in this category.
The 90-day window matters because most episodic health needs resolve within 30 days. A patient returning within 90 days is coming back proactively for a new or continuing need, which indicates trust in the platform rather than just necessity during an acute episode.
Consult-to-Repeat Rate
Consult-to-Repeat Rate measures the percentage of patients who have had two or more consultations on your platform out of all patients who have ever consulted. It is a stickiness metric that captures whether patients are building a habit of using your platform rather than treating it as a one-time service. A high consult-to-repeat rate signals genuine platform preference and trust.
The difference between a patient who consulted once and one who consulted twice is enormous in unit economics terms. The second consultation was acquired at near-zero marginal cost, which dramatically lowers the effective CAC over the patient’s lifetime and improves the LTV:CAC ratio without any additional marketing spend.
Follow-up Rate
Follow-up Rate measures the percentage of all consultations on the platform that are follow-up consultations, meaning the patient is returning for continued care on an existing condition rather than a new presenting problem. A high Follow-up Rate indicates that your platform is functioning as a care continuity provider rather than just an acute-episode service.
Follow-up consultations have fundamentally better economics than first-time consultations: lower effective acquisition cost (the patient is already on the platform), higher completion rate (motivated returning patients), and higher likelihood of pharmacy and diagnostic orders because they are managing ongoing conditions.
Patient Acquisition Economics
Acquisition economics in healthtech operate under a specific constraint: patient acquisition is expensive relative to the per-consultation revenue, which means the LTV of each patient must be high enough to justify the acquisition cost. These three metrics measure whether your acquisition investment is building a viable long-term business or simply buying short-term volume.
Patient Acquisition Cost (PAC)
Patient Acquisition Cost is the total sales and marketing spend divided by the number of new patients acquired in the same period. It captures everything spent to get a patient to their first consultation: digital advertising, influencer campaigns, referral bonuses, hospital partnerships, and any other demand-generation cost.
PAC must be calculated separately by channel. Organic or word-of-mouth patients arrive at near-zero PAC, while paid digital acquisition in health categories can be expensive due to platform restrictions on health advertising. Blending channels hides the true cost of your most expensive acquisition mechanisms.
LTV:CAC Ratio
The LTV:CAC Ratio tests the fundamental viability of your healthtech business model. If what a patient returns over their lifetime on the platform is less than three times what you spent to acquire them, the business is not generating enough margin to cover acquisition, operations, and growth investment simultaneously.
For a telemedicine platform with ARPU of Rs. 600, gross margin of 40%, and monthly churn of 5%, LTV = (600 x 0.40) / 0.05 = Rs. 4,800. If PAC is Rs. 800, LTV:CAC = 6:1, which is healthy. If PAC is Rs. 2,500, LTV:CAC = 1.9:1, which is not sustainable.
CAC Payback Period
CAC Payback Period measures how many months of patient activity are required before the platform recoups the cost of acquiring that patient through gross profit generated. It is a cash efficiency metric that tells you how long your acquisition capital is tied up before you start seeing a return.
For a platform with PAC of Rs. 600, ARPU of Rs. 600, and gross margin of 40%, the monthly gross profit per patient is Rs. 240, and the payback period is 2.5 months. That is an excellent outcome. If ARPU is Rs. 300 and gross margin is 30%, monthly gross profit is Rs. 90 and payback stretches to 6.7 months, which is still acceptable but leaves less room for churn before LTV is impacted.
Quality Metrics
Quality metrics in healthtech are not just patient experience scores. They are also revenue expansion signals. A diagnostic order and a strong NPS score both reflect the same underlying reality: the patient trusted the doctor and the platform enough to act on the recommendation. Quality and revenue are more tightly connected in healthcare than in almost any other category.
Diagnostic Order Rate
Diagnostic Order Rate measures the percentage of consultations that result in a diagnostic test being booked through the platform. Like prescription fulfillment, diagnostics represent a high-value revenue expansion opportunity on top of the consultation fee. A patient who books a blood test, an ECG, or an ultrasound through your platform generates significant additional revenue and is also signaling that they trust the platform’s end-to-end care delivery.
Diagnostic margins tend to be higher than pharmacy margins when the platform operates its own sample collection network or partners directly with diagnostic labs on a revenue-sharing basis. For platforms that pass diagnostic orders to third-party partners, the commission per test is typically Rs. 100 to Rs. 400 depending on test type.
Net Promoter Score (NPS)
Net Promoter Score measures the percentage of patients who would actively recommend your platform to others, minus those who would not. In healthcare, NPS is more than a satisfaction score. It is a proxy for clinical trust and a predictor of organic patient acquisition, which is the most cost-efficient patient source a telemedicine platform can build.
A high NPS in healthcare means patients felt heard, cared for, and confident in the advice they received. These patients drive word-of-mouth referrals, leave reviews that reduce paid acquisition costs, and are far more likely to become repeat patients themselves. NPS is simultaneously a retention predictor and an acquisition cost reduction signal.
Healthtech Benchmarks for Indian Startups
These benchmarks are calibrated for Indian telemedicine and digital health platforms at different stages of maturity. Early-stage benchmarks reflect a platform that has found product-market fit but is still growing its patient base. Growth stage reflects platforms with Rs. 10 to Rs. 50 crore ARR equivalent. Mature reflects platforms at scale with strong retention and monetization infrastructure in place.
“In telemedicine, the first consultation tells you nothing. The second one tells you everything. A patient who returns has made a choice to trust your platform over every other option available to them, and that choice is the only unit economic that actually compounds.”
Ankit Sarawagi, CFOmatrixNeed help modeling your healthtech unit economics? CFOmatrix helps digital health founders build the metrics framework that investors and operators actually rely on, before and after fundraising. | Talk to CFOmatrix |
Frequently Asked Questions
What doctor utilization rate makes a telemedicine platform financially viable?
A doctor utilization rate of 60% or above is the threshold for financial viability on most telemedicine platforms. Below 60%, the fixed cost of keeping doctors available on the platform exceeds what consultation revenue can cover, creating a structural loss on the supply side. Platforms targeting specialist doctors, where per-consultation fees are higher, can sustain viability at slightly lower utilization rates, but the principle remains the same: idle supply is a direct cost with no corresponding revenue, and it compounds quickly when you have a large doctor network.
How is patient LTV calculated for a healthtech startup?
Patient LTV = (ARPU x Gross Margin %) / Monthly Churn Rate. For example, if your ARPU is Rs. 600 per month, your gross margin is 40%, and your monthly churn rate is 5%, then LTV = (600 x 0.40) / 0.05 = Rs. 4,800. The key mistake is using revenue instead of gross profit in this formula, which significantly overstates LTV. Healthtech gross margins are typically 35% to 55%, not 70% to 80% like SaaS, so the distinction between revenue and gross profit has a very large impact on the resulting LTV figure and the LTV:CAC ratio that follows from it.
What patient acquisition cost should a telemedicine startup target in India?
A Patient Acquisition Cost (PAC) between Rs. 200 and Rs. 800 is the viable range for telemedicine platforms in India. General telemedicine apps targeting high-volume, low-ticket consultations need PAC closer to Rs. 200 to Rs. 400 to maintain viable LTV:CAC ratios. Specialist platforms with higher ARPU can absorb PAC up to Rs. 800 and still achieve a 3:1 LTV:CAC. Above Rs. 800, the economics become difficult unless the platform has strong prescription fulfillment or diagnostics revenue alongside consultations. Reducing PAC over time through referral programs and organic growth is one of the most effective ways to improve healthtech unit economics at scale.
Why is consult-to-repeat rate more important than total consultations for healthtech unit economics?
Total consultations measure volume, but they do not tell you whether patients are choosing to come back or being acquired fresh each time. A platform with 10,000 monthly consultations but a 10% consult-to-repeat rate is essentially running a one-time-use service, spending acquisition cost on every patient repeatedly. A platform with 5,000 monthly consultations and a 35% consult-to-repeat rate is building a compounding base of returning patients, which dramatically improves LTV, lowers effective PAC over time, and creates a much more defensible business. Repeat consultation behavior is the clearest signal of patient trust, and patient trust is the foundation of every durable healthtech business.
How does prescription fulfillment revenue change the unit economics of telemedicine?
Prescription fulfillment revenue fundamentally transforms telemedicine unit economics by adding a high-margin revenue stream on top of the consultation fee. A platform that earns Rs. 400 per consultation but also captures Rs. 600 in pharmacy margin when the patient fills the prescription on the platform doubles its effective revenue per patient interaction. This improves LTV significantly, makes a higher PAC justifiable, and shifts the business from a low-margin consultation marketplace toward a higher-margin integrated healthcare platform. Platforms targeting a prescription fulfillment rate above 30% of consultations can sustain acquisition costs that pure-play telemedicine apps cannot, which is why the largest Indian healthtech platforms have all made pharmacy fulfillment a central part of their business model.
Related Articles
Unit Economics Every Startup Must Track: The Complete CFO Guide SaaS Unit Economics: 18 Metrics Every Startup Must Track in 2026 Edtech Unit Economics: Metrics Every Education Startup Must TrackAS | Founder, CFOmatrix | Finance Strategy & Equity Compliance CFOmatrix is a knowledge platform focused on how finance actually works inside growing companies. Every insight is shaped by real operating experience across startups and growth-stage companies, including cross-border setups. |